Medications
Pain Management
Antirheumatic Agents
Adalimumab | HUMIRA |
Anakinra | KINERET |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of injection site reactions
D – diagnosis may dictate restriction
Azathioprine | IMURAN |
A – approved while on duty
D – diagnosis may dictate restriction
Etanercept | ENBREL |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of injection site reactions
D – diagnosis may dictate restriction
Hydroxychloroquine | PLAQUENIL |
T – temporary restriction at beginning of treatment; monitor for visual disturbances, dizziness, and behavior changes
D – diagnosis may dictate restriction
Infliximab | REMICADE |
S – approved if taken off duty (with appropriate delay before returning to full duty, to assure that there are no further residual effects); risk of infusion reactions
D – diagnosis may dictate restriction
Leflunomide | ARAVA |
Methotrexate | RHEUMATREX |
Penicillamine | CUPRIMINE |
Sulfasalazine | AZULFIDINE |
A – approved while on duty
D – diagnosis may dictate restriction
Muscle Relaxants
Baclofen | LIORESAL |
Carisoprodol | SOMA |
Chlorzoxazone | PARAFON |
Cyclobenzaprine | FLEXERIL |
Dantrolene | DANTRIUM |
Metaxalone | SKELAXIN |
Methocarbamol | ROBAXIN |
Orphenadrine | NORFLEX |
Tizanidine | ZANAFLEX |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Nonsteroidal Anti-Inflammatory Agents
Aspirin | |
Celecoxib | CELEBREX |
Choline magnesium trisalicylate | TRILISATE |
Diclofenac | VOLTAREN |
Diclofenac and misoprostol | ARTHROTEC |
Diflunisal | DOLOBID |
Etodolac | LODINE |
Flurbiprofen | ANSAID |
Ibuprofen | ADVIL, MOTRIN |
Indomethacin | INDOCIN |
Ketoprofen | ORUDIS |
Ketorolac | TORADOL |
Mefenamic acid | PONSTEL |
Meloxicam | MOBIC |
Nabumetone | RELAFEN |
Naproxen | NAPROSYN |
Oxaprozin | DAYPRO |
Piroxicam | FELDENE |
Salsalate | DISALCID |
Sulindac | CLINORIL |
Tolmetin | TOLECTIN |
A – approved while on duty
Opioids
Buprenorphine | SUBUTEX |
Buprenorphine and naloxone | SUBOXONE |
R – approved only if assigned to restricted duty; risk of sedation
Butorphanol | STADOL |
Codeine |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Fentanyl | DURAGESIC, SUBLIMAZE |
R – approved only if the officer is assigned to restricted duty (transdermal forms)
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects) (injectable and oral forms); risk of sedation
D – diagnosis may dictate restriction
Hydromorphone | DILAUDID |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedationD – diagnosis may dictate restriction
Levorphanol | LEVO-DROMORAN |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Meperidine | DEMEROL |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Methadone |
R – approved only if LEO is assigned to restricted duty; risk of sedation
Morphine short acting | MSIR |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Morphine long acting | AVINZA, KADIAN, MS CONTIN |
R – approved only if the officer is assigned to restricted duty; risk of sedation
Nalbuphine | NUBAIN |
S – approved if taken off duty (with appropriate delay before returning to full duty, to assure that there are no further residual effects); risk of sedation D – diagnosis may dictate restriction
Oxycodone short acting |
S – approved if taken off duty/8 hours (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Oxycodone long acting | OXYCONTIN |
R – approved only if the officer is assigned to restricted duty; risk of sedation
Oxymorphone short acting | OPANA IR |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Oxymorphone long acting | OPANA ER |
R – approved only if the officer is assigned to restricted duty
Pentazocine | TALWIN |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Propoxyphene | DARVON |
S – approved if taken off duty/8 hours (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Opioid Analgesic Combinations
Acetaminophen and codeine | TYLENOL #2, TYLENOL #3, TYLENOL #4 |
Acetaminophen and hydrocodone | NORCO, LORTAB, VICODIN |
Acetaminophen and oxycodone | PERCOCET |
Acetaminophen and propoxyphene | DERVOCET |
Acetaminophen and pentazocine | TALACEN |
Aspirin and oxycodone | PERCODAN |
Ibruprofen and hydrocodone | VICOPROFEN |
Ibuprofen and oxycodone |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Other Pain Management Medications
Acetaminophen | TYLENOL |
A – approved while on duty
Acetaminophen and tramadol | ULTRACET |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction
Hylan G-F 20 | SYNVISC |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of joint pain and swelling
D – diagnosis may dictate restriction
Tramadol | ULTRAM |
S – approved if taken off duty (with appropriate delay before returning to full duty to assure that there are no further residual effects); risk of sedation
D – diagnosis may dictate restriction